You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Chronic myeloid leukemia (CML)

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Asciminib RMP Study

Not yet recruiting
  • Chronic Myeloid Leukemia
  • Asciminib
  • (no location specified)
Jul 5, 2023

Chronic Myeloid Leukemia (CML) Trial in France

Recruiting
  • Chronic Myeloid Leukemia (CML)
    • Annecy, France
    • +11 more
    Jul 18, 2023

    Tyrosine Kinase Inhibitors, Chronic Myeloid Leukemia Trial in Poitiers (treatment of TKI in CML)

    Not yet recruiting
    • Tyrosine Kinase Inhibitors
    • Chronic Myeloid Leukemia
    • treatment of TKI in CML
    • Poitiers, France
      Chu Poitiers
    Feb 21, 2023

    Condition Vasoregulation Function Endothelium in CML Getting TKI

    Recruiting
    • Chronic Myeloid Leukaemia
    • taking blood for the study of biochemical parameters and the study of microcirculation using the method of laser Doppler flowmetry
    • Moscow, Russian Federation
    • +1 more
    Jan 11, 2023

    CML (Chronic Myelogenous Leukemia Trial (KDS-1001)

    Not yet recruiting
    • CML (Chronic Myelogenous Leukemia
    • (no location specified)
    Jul 27, 2022

    Treatment Free Remission (TFR) in CML Patients (CML-CP)Study

    Not yet recruiting
    • Chronic Myeloid Leukemia
    • Treatment-free Remission
    • TFR(Treatment-Free Remission)
    • (no location specified)
    Jun 27, 2022

    CML, Chronic Phase Trial in Harbin (Flumatinib, Imatinib)

    Not yet recruiting
    • CML, Chronic Phase
    • Harbin, Heilongjiang, China
      Institute of Hematology and Oncology, Harbin The First Hospital
    May 5, 2022

    Chronic Myeloid Leukemia Trial in New York (Nilotinib)

    Completed
    Has Results
    • Chronic Myeloid Leukemia
    • New York, New York
      Weill Cornell Medical College
    Mar 24, 2022

    Metabolic Alternation and Clinicohematological Characteristic in

    Not yet recruiting
    • CML, Chronic Phase
    • Tyrosine kinase inhibitor
    • (no location specified)
    Nov 6, 2023

    CML Trial in Ciudad Autonoma de Buenos Aire (Discontinuing treatment with Tyrosine Kinase Inhibitor after enrolment)

    Recruiting
    • CML
    • Discontinuing treatment with Tyrosine Kinase Inhibitor after enrolment
    • Ciudad Autonoma de Buenos Aire, Ciudad Autonoma De Buenos Aires, Argentina
      FUNDALEU
    Jun 29, 2023

    According to Molecular Identification at Diagnosis

    Not yet recruiting
    • Chronic Myeloid Leukemia
    • Next Generation Sequencing (DNA and RNA)
    • (no location specified)
    Oct 28, 2022

    CML, Chronic Phase, CML, Accelerated Phase Trial in Wuhan (HS-10382(Part 1: Dose escalation), HS-10382(Part 2: Dose expansion))

    Recruiting
    • CML, Chronic Phase
    • CML, Accelerated Phase
    • HS-10382(Part 1: Dose escalation)
    • HS-10382(Part 2: Dose expansion)
    • Wuhan, Hubei, China
      Union Hospital affiliated to Tongji Medical College of Huazhong
    Jan 12, 2023

    Ponatinib in CML Patients in Chronic Phase

    Recruiting
    • Chronic Myeloid Leukemia, Chronic Phase
    • Therapeutic drug monitoring
    • Molecular Response
    • Cagliari, Italy
    • +4 more
    Nov 3, 2023

    Concomitant Medications at CML Diagnosis

    Completed
    • Chronic Myeloid Leukemia
    • the prevalence of comorbid conditions
    • (no location specified)
    Sep 16, 2023

    B-cell Acute Lymphoblastic Leukemia, Chronic Myeloid Leukemia (CML) in Lymphoid Blast Crisis, Philadelphia Chromosome Positive

    Recruiting
    • B-cell Acute Lymphoblastic Leukemia
    • +2 more
    • Chicago, Illinois
    • +5 more
    Dec 27, 2021

    Chronic Myeloid Leukemia (CML), Pancreatic Ca, Colon/Rectal Ca Trial run by the National Heart, Lung, and Blood Institute

    Completed
    • Chronic Myeloid Leukemia (CML)
    • +4 more
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Dec 31, 2022

    Chronic Myeloid Leukemia, Chronic Phase, Adult CML, Leukemia, Myeloid Trial in Augusta, Milwaukee (Asciminib, Ascimininb +

    Recruiting
    • Chronic Myeloid Leukemia, Chronic Phase
    • +3 more
    • Augusta, Georgia
    • +1 more
    Jul 14, 2022

    Chronic Myeloid Leukemia Trial (Asciminib)

    Available
    • Chronic Myeloid Leukemia
    • (no location specified)
    Jan 17, 2023

    Chronic Myeloid Leukemia in Myeloid Blast Crisis, Chronic Myeloid Leukaemia Transformation, Chronic Myeloid Leukemia -

    Recruiting
    • Chronic Myeloid Leukemia in Myeloid Blast Crisis
    • +3 more
    • based decitabine and olverembatinib（HQP1351)chemotherapy
    • Guanzhou, China
      Department of Hematology, Nanfang Hospital, Southern Medical Uni
    Dec 6, 2022

    3rd Line Therapy or More to Treat Adult CML- CP in Real World

    Not yet recruiting
    • Chronic Myeloid Leukemia
    • Asciminib
    • (no location specified)
    Oct 16, 2023

    Philadelphia Chromosome Negative, BCR-ABL1 Positive Chronic Myelogenous Leukemia Trial in Houston (Asciminib)

    Recruiting
    • Philadelphia Chromosome Negative, BCR-ABL1 Positive Chronic Myelogenous Leukemia
    • Houston, Texas
      M D Anderson Cancer Center
    Feb 1, 2022

    Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive,

    Completed
    • Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
    • +4 more
    • Eltrombopag Olamine
    • Houston, Texas
      M D Anderson Cancer Center
    Jan 4, 2022

    Among CP-CML Participants Initiating Dasatinib inReal Life

    Completed
    • Chronic Myeloid Leukemia
    • Non-Interventional
    • Paris, France
      Local Institution
    Jun 17, 2022

    Needs of 3L+ CP-CML and With T315I-mutated CML Patients

    Completed
    • Chronic Myeloid Leukemia
    • 3L Therapy
    • T315I
    • Lyon, France
      Novartis Investigative Site
    Nov 9, 2022

    Myeloproliferative Tumor, Chronic Phase Chronic Myelogenous Leukemia, Chronic Myeloid Leukemia Trial in San Francisco (Online

    Recruiting
    • Myeloproliferative Neoplasm
    • +2 more
    • Online Mindfulness Meditation
    • Internet-Based Webinars
    • San Francisco, California
      University of California San Francisco
    Aug 9, 2022